This is the last of the three-part podcast series, Keeping up with the Chemos on CDK 4/6 inhibitors. Our multidisciplinary panel will discuss the challenges with patient monitoring while on CDK 4/6 inhibitors. When to dose adjust and hold or even discontinue CDK 4/6 inhibitors. Once again, the podcast ends with take home points for patient monitoring, medication management, and side effects while on CDK 4/6 inhibitors.  

2024-2025 SGO Chemotherapy and Immunology Subcommittee Lead and Moderator:
Jennifer MacDonald, PharmD, BCOP
 
Speakers: 
Julia Fehniger, MD
Jodi L. Taraba, PharmD, MS, RPh, BCOP
Siddhartha Yadav, M.B.B.S, MD